SCHEMBL6420524

SCHEMBL6420524

CCCCCCCC[SiH2][SiH2]CCCCl

nearest known ligand 0.60

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
TSHR P16473 7/20 0.60
ALDH1A1 P00352 5/20 0.60
TDP1 Q9NUW8 3/20 0.50
THRB P10828 1/20 0.42
FAAH O00519 2/20 0.41
CES2 O00748 3/20 0.35
CES1 P23141 3/20 0.35
PLA2G1B P04054 1/20 0.34
HSP90AA1 P07900 1/20 0.34
RAD52 P43351 1/20 0.34
ATG4B Q9Y4P1 1/20 0.34
PPARG P37231 4/20 0.33
PPARD Q03181 4/20 0.33
PPARA Q07869 4/20 0.33
GPR84 Q9NQS5 3/20 0.33
HDAC11 Q96DB2 3/20 0.33
DNM1 Q05193 2/20 0.33
HSD17B10 Q99714 2/20 0.33
SLC22A6 Q4U2R8 1/20 0.33
SLC22A8 Q8TCC7 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6419843 1.00 TSHR (0.60) TSHRALDH1A1TDP1THRBFAAH
SCHEMBL8469122 0.86 TSHR (0.57) TSHRALDH1A1THRBCES2CES1
SCHEMBL8380675 0.86 TSHR (0.57) TSHRALDH1A1THRBCES2CES1
SCHEMBL9191869 0.84 TSHR (0.60) TSHRALDH1A1TDP1THRBFAAH
SCHEMBL6422760 0.83
SCHEMBL8384635 0.83 TSHR (0.50) TSHRALDH1A1THRBCES2CES1
SCHEMBL31216189 0.79 TSHR (0.68) TSHRALDH1A1TDP1THRBFAAH
SCHEMBL1248751 0.78 TSHR (0.47) TSHRALDH1A1THRBCES2CES1
SCHEMBL11742005 0.76 TSHR (1.00) TSHRALDH1A1TDP1THRBFAAH
SCHEMBL5571322 0.76 TSHR (1.00) TSHRALDH1A1TDP1THRBFAAH

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6946537-B2 Siloxane oligomers, a process for their production and their use DEGUSSA AG (DE) 2005-09-20 US disclosed
US-20040158090-A1 Siloxane oligomers, a process for their production and their use EVONIK DEGUSSA GMBH (DE) 2004-08-12 US disclosed
US-20030018155-A1 Siloxane oligomers, a process for their production and their use DEGUSSA AG (DE) 2003-01-23 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20040158090-A1 Siloxane oligomers, a process for their production and their use SAAL1, RAD54L, RTF1 TSHR 3723/4885ALDH1A1 216/4885TDP1 3208/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.